Please Wait...

TGF-β1 // Transforming Growth Factor beta 1

Biomarker Therapeutic Areas: 
Biomarker Matrices: 

Transforming Growth Factor β1 (TGF-β1), an homodimer of two 12.5 kDa subunits, belongs to the TGF β superfamily which comprises Bone Morphogenetic Proteins, activins, inhibins, growth differentiation factors and myostatin. There are three isoforms of TGF β (TGF-β1, TGF-β2 and TGF-β3) encoded by three different genes. Even if these three isoforms interact with the same receptor (heterodimer of TGFR-1 and TGFR-2), they are implicated in slightly different biological functions (Lafyatis, 2014). TGF-β1 is secreted together with its latency associated pro-peptide (LAP), is active only after a complete posttranslational process and releasing from LAP association (which can be, for example, provoked by mechanical stimulation) (Hinz, 2015). TGF-β family is implicated in numerous biological process such as regulation of cell proliferation, migration and adhesion of differentiated cells, extracellular matrix production, induction of stromal cytokine, fibrosis and in modifying tumor micro-environment (Massagué, 2012).

Bioclinica Lab employs a manual sandwich immunoassay specific for TGF-β1 measurement in serum.

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

With many clinical trials slowed or terminated, investments in new technologies are difficult. Yet, a #CTMS with a… https://t.co/VRIhWWf4tE
Bioclinica (5 days ago)
With Bioclinica #CTMS, sponsors & CROs have access to a full-featured, scalable system - a single, centralized sour… https://t.co/7ACrv8cvuF
Bioclinica (1 week ago)
Now available: a DIY #EDC solution. From study start-up to close-out, Bioclinica EDC Solo is an efficient, cost-eff… https://t.co/vFhC7ITfZV
Bioclinica (2 weeks ago)
Reduce the number of user requirement iterations and UAT findings during the #IRT build process. With the agile app… https://t.co/TJt2sZlrFP
Bioclinica (2 weeks ago)
Don't compromise with manual systems and spreadsheets. As an entry-level system with phased implementation, Bioclin… https://t.co/qIpi1MESXw
Bioclinica (3 weeks ago)
According to our recent poll, 45% of respondents had neither a #CTMS nor an #eTMF system, while only 24% had both.… https://t.co/l4dKC7pBQo
Bioclinica (3 weeks ago)